Altered development of NKT cells, γδ T cells, CD8 T cells and NK cells in a PLZF deficient patient

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Eidson, Maggie ^a,f   Wahlstrom, Justin ^a,g   Beaulieu, Aimee M ^a   Zaidi, Bushra ^a   Carsons, Steven E ^b   Crow, Peggy K ^c,d   Yuan, Jianda ^a   Wolchok, Jedd D ^a   Horsthemke, Bernhard ^e   Wieczorek, Dagmar ^e   Sant'Angelo, Derek B ^a,d  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b WINTHROP UNIVERSITY HOSPITAL   (United States)

^c HOSPITAL FOR SPECIAL SURGERY   (United States)

^d Weill Cornell Graduate School of Biomedical Sciences   (United States)

^e UNIVERSITY HOSPITAL ESSEN   (Germany)

^f MIAMI CHILDREN'S HOSPITAL   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PLZF; UNCLASSIFIED DRUG; KRUPPEL LIKE FACTOR; LYMPHOCYTE ANTIGEN RECEPTOR; ZBTB16 PROTEIN, HUMAN;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL EXPANSION; CELL MATURATION; CONTROLLED STUDY; GAMMA DELTA T LYMPHOCYTE; GROWTH REGULATION; HUMAN; HUMAN CELL; MELANOMA; METASTASIS POTENTIAL; MOUSE; NATURAL KILLER CELL; NATURAL KILLER T CELL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; T LYMPHOCYTE SUBPOPULATION; CELL CULTURE; FLOW CYTOMETRY; GENETICS; IMMUNOLOGY; METABOLISM; REAL TIME POLYMERASE CHAIN REACTION;

MUS;

CD8-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; FLOW CYTOMETRY; HUMANS; KILLER CELLS, NATURAL; KRUPPEL-LIKE TRANSCRIPTION FACTORS; MELANOMA; NATURAL KILLER T-CELLS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; T-LYMPHOCYTE SUBSETS;

EID: 80052432708     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0024441     Document Type: Article

References (51)

1. Kelly KF, Daniel JM, (2006) POZ for effect--POZ-ZF transcription factors in cancer and development. Trends Cell Biol 16: 578-587.
2. Dent AL, Shaffer AL, Yu X, Allman D, Staudt LM, (1997) Control of inflammation, cytokine expression, and germinal center formation by BCL-6. Science 276: 589-592.
3. Fukuda T, Yoshida T, Okada S, Hatano M, Miki T, et al. (1997) Disruption of the Bcl6 gene results in an impaired germinal center formation. J Exp Med 186: 439-448.
4. Nurieva RI, Chung Y, Martinez GJ, Yang XO, Tanaka S, et al. (2009) Bcl6 mediates the development of T follicular helper cells. Science 325: 1001-1005.
5. Yu D, Rao S, Tsai LM, Lee SK, He Y, et al. (2009) The transcriptional repressor Bcl-6 directs T follicular helper cell lineage commitment. Immunity 31: 457-468.
6. He X, Park K, Kappes DJ, (2010) The role of ThPOK in control of CD4/CD8 lineage commitment. Annu Rev Immunol 28: 295-320.
7. Maeda T, Merghoub T, Hobbs RM, Dong L, Maeda M, et al. (2007) Regulation of B versus T lymphoid lineage fate decision by the proto-oncogene LRF. Science 316: 860-866.
8. Sakaguchi S, Hombauer M, Bilic I, Naoe Y, Schebesta A, et al. (2010) The zinc-finger protein MAZR is part of the transcription factor network that controls the CD4 versus CD8 lineage fate of double-positive thymocytes. Nat Immunol 11: 442-448.
9. Scaglioni PP, Pandolfi PP, (2007) The theory of APL revisited. Curr Top Microbiol Immunol 313: 85-100.
10. He LZ, Guidez F, Tribioli C, Peruzzi D, Ruthardt M, et al. (1998) Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL. Nat Genet 18: 126-135.
11. Barna M, Hawe N, Niswander L, Pandolfi PP, (2000) Plzf regulates limb and axial skeletal patterning. Nat Genet 25: 166-172.
12. Avantaggiato V, Pandolfi PP, Ruthardt M, Hawe N, Acampora D, et al. (1995) Developmental analysis of murine Promyelocyte Leukemia Zinc Finger (PLZF) gene expression: implications for the neuromeric model of the forebrain organization. J Neurosci 15: 4927-4942.
13. Buaas FW, Kirsh AL, Sharma M, McLean DJ, Morris JL, et al. (2004) Plzf is required in adult male germ cells for stem cell self-renewal. Nat Genet 36: 647-652.
14. Costoya JA, Hobbs RM, Barna M, Cattoretti G, Manova K, et al. (2004) Essential role of Plzf in maintenance of spermatogonial stem cells. Nat Genet 36: 653-659.
15. Doulatov S, Notta F, Rice KL, Howell L, Zelent A, et al. (2009) PLZF is a regulator of homeostatic and cytokine-induced myeloid development. Genes Dev 23: 2076-2087.
16. Kovalovsky D, Uche OU, Eladad S, Hobbs RM, Yi W, et al. (2008) The BTB-zinc finger transcriptional regulator PLZF controls the development of invariant natural killer T cell effector functions. Nat Immunol 9: 1055-1064.
17. Savage AK, Constantinides MG, Han J, Picard D, Martin E, et al. (2008) The transcription factor PLZF directs the effector program of the NKT cell lineage. Immunity 29: 391-403.
18. Bendelac A, Savage PB, Teyton L, (2007) The biology of NKT cells. Annu Rev Immunol 25: 297-336.
19. Kronenberg M, Gapin L, (2002) The unconventional lifestyle of NKT cells. Nat Rev Immunol 2: 557-568.
20. Berzofsky JA, Terabe M, (2009) The contrasting roles of NKT cells in tumor immunity. Curr Mol Med 9: 667-672.
21. Benlagha K, Weiss A, Beavis A, Teyton L, Bendelac A, (2000) In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers. J Exp Med 191: 1895-1903.
22. Matsuda JL, Naidenko OV, Gapin L, Nakayama T, Taniguchi M, et al. (2000) Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J Exp Med 192: 741-754.
23. Hammond KJ, Pellicci DG, Poulton LD, Naidenko OV, Scalzo AA, et al. (2001) CD1d-restricted NKT cells: an interstrain comparison. J Immunol 167: 1164-1173.
24. Marsh RA, Villanueva J, Kim MO, Zhang K, Marmer D, et al. (2009) Patients with X-linked lymphoproliferative disease due to BIRC4 mutation have normal invariant natural killer T-cell populations. Clin Immunol 132: 116-123.
25. Baev DV, Peng XH, Song L, Barnhart JR, Crooks GM, et al. (2004) Distinct homeostatic requirements of CD4+ and CD4- subsets of Valpha24-invariant natural killer T cells in humans. Blood 104: 4150-4156.
26. Berzins SP, Cochrane AD, Pellicci DG, Smyth MJ, Godfrey DI, (2005) Limited correlation between human thymus and blood NKT cell content revealed by an ontogeny study of paired tissue samples. Eur J Immunol 35: 1399-1407.
27. Kovalovsky D, Alonzo ES, Uche OU, Eidson M, Nichols KE, et al. (2010) PLZF induces the spontaneous acquisition of memory/effector functions in T cells independently of NKT cell-related signals. J Immunol 184: 6746-6755.
28. Raberger J, Schebesta A, Sakaguchi S, Boucheron N, Blomberg KE, et al. (2008) The transcriptional regulator PLZF induces the development of CD44 high memory phenotype T cells. Proc Natl Acad Sci U S A 105: 17919-17924.
29. Alonzo ES, Gottschalk RA, Das J, Egawa T, Hobbs RM, et al. (2010) Development of promyelocytic zinc finger and ThPOK-expressing innate gamma delta T cells is controlled by strength of TCR signaling and Id3. J Immunol 184: 1268-1279.
30. Kreslavsky T, Savage AK, Hobbs R, Gounari F, Bronson R, et al. (2009) TCR-inducible PLZF transcription factor required for innate phenotype of a subset of gammadelta T cells with restricted TCR diversity. Proc Natl Acad Sci U S A 106: 12453-12458.
31. Felices M, Yin CC, Kosaka Y, Kang J, Berg LJ, (2009) Tec kinase Itk in gammadeltaT cells is pivotal for controlling IgE production in vivo. Proc Natl Acad Sci U S A 106: 8308-8313.
32. Verykokakis M, Boos MD, Bendelac A, Adams EJ, Pereira P, et al. (2010) Inhibitor of DNA binding 3 limits development of murine slam-associated adaptor protein-dependent "innate" gammadelta T cells. PLoS One 5: e9303.
33. Weinreich MA, Odumade OA, Jameson SC, Hogquist KA, (2010) T cells expressing the transcription factor PLZF regulate the development of memory-like CD8+ T cells. Nat Immunol 11: 709-716.
34. Renukaradhya GJ, Khan MA, Vieira M, Du W, Gervay-Hague J, et al. (2008) Type I NKT cells protect (and type II NKT cells suppress) the host's innate antitumor immune response to a B-cell lymphoma. Blood 111: 5637-5645.
35. Swann JB, Uldrich AP, van Dommelen S, Sharkey J, Murray WK, et al. (2009) Type I natural killer T cells suppress tumors caused by p53 loss in mice. Blood 113: 6382-6385.
36. Teng MW, Sharkey J, McLaughlin NM, Exley MA, Smyth MJ, (2009) CD1d-based combination therapy eradicates established tumors in mice. J Immunol 183: 1911-1920.
37. Teng MW, Yue S, Sharkey J, Exley MA, Smyth MJ, (2009) CD1d activation and blockade: a new antitumor strategy. J Immunol 182: 3366-3371.
38. Tahir SM, Cheng O, Shaulov A, Koezuka Y, Bubley GJ, et al. (2001) Loss of IFN-gamma production by invariant NK T cells in advanced cancer. J Immunol 167: 4046-4050.
39. van der Vliet HJ, Pinedo HM, von Blomberg BM, van den Eertwegh AJ, Scheper RJ, et al. (2002) Natural Killer T cells. Lancet Oncol 3: 574.
40. Motohashi S, Nakayama T, (2009) Invariant natural killer T cell-based immunotherapy for cancer. Immunotherapy 1: 73-82.
41. Novak J, Griseri T, Beaudoin L, Lehuen A, (2007) Regulation of type 1 diabetes by NKT cells. Int Rev Immunol 26: 49-72.
42. Wither J, Cai YC, Lim S, McKenzie T, Roslin N, et al. (2008) Reduced proportions of natural killer T cells are present in the relatives of lupus patients and are associated with autoimmunity. Arthritis Res Ther 10: R108.
43. Van Kaer L, (2006) Role of invariant natural killer T cells in immune regulation and as potential therapeutic targets in autoimmune disease. Expert Rev Clin Immunol 2: 745-757.
44. Fischer S, Kohlhase J, Bohm D, Schweiger B, Hoffmann D, et al. (2008) Biallelic loss of function of the promyelocytic leukaemia zinc finger (PLZF) gene causes severe skeletal defects and genital hypoplasia. J Med Genet 45: 731-737.
45. Mitsuo A, Morimoto S, Nakiri Y, Suzuki J, Kaneko H, et al. (2006) Decreased CD161+CD8+ T cells in the peripheral blood of patients suffering from rheumatic diseases. Rheumatology (Oxford) 45: 1477-1484.
46. Kosub DA, Lehrman G, Milush JM, Zhou D, Chacko E, et al. (2008) Gamma/Delta T-cell functional responses differ after pathogenic human immunodeficiency virus and nonpathogenic simian immunodeficiency virus infections. J Virol 82: 1155-1165.
47. Lee YJ, Jeon YK, Kang BH, Chung DH, Park CG, et al. (2010) Generation of PLZF+ CD4+ T cells via MHC class II-dependent thymocyte-thymocyte interaction is a physiological process in humans. J Exp Med 207: 237-246.
48. Martin E, Treiner E, Duban L, Guerri L, Laude H, et al. (2009) Stepwise development of MAIT cells in mouse and human. PLoS Biol 7: e54.
49. Takahashi T, Dejbakhsh-Jones S, Strober S, (2006) Expression of CD161 (NKR-P1A) defines subsets of human CD4 and CD8 T cells with different functional activities. J Immunol 176: 211-216.
50. Billerbeck E, Kang YH, Walker L, Lockstone H, Grafmueller S, et al. (2010) Analysis of CD161 expression on human CD8+ T cells defines a distinct functional subset with tissue-homing properties. Proc Natl Acad Sci U S A 107: 3006-3011.
51. Turtle CJ, Swanson HM, Fujii N, Estey EH, Riddell SR, (2009) A distinct subset of self-renewing human memory CD8+ T cells survives cytotoxic chemotherapy. Immunity 31: 834-844.